Frequent/massive administration of anticancer agents frequently causes mucositis. This condition involves the entire oral cavity in many cases, inducing pain and hemorrhage. Therefore, it decreases dietary intake, markedly reducing the quality of life (QOL). [1][2][3] In addition, severe mucositis influences the administration schedule of anticancer agents, affecting cancer treatment. Thus, it is important to prevent and treat chemotherapy-induced mucositis.Chemotherapy-induced mucositis is associated with two factors. [4][5][6] First, free radicals produced by anticancer agents act on the oral mucosa as oxidative stress, destroying the mucosal tissue and causing mucositis. Secondly, the oral cavity enters an infection-prone state via the bone marrow-suppressing effects of anticancer agents, resulting in mucositis via bacterial infection. However, actually, these two factors may be intricately involved. Therefore, it is important to inhibit excessive anticancer agent-related oxidative stress and prevent bacterial infection in the oral cavity, for the prevention and treatment of mucositis.Currently, chemotherapy-induced mucositis is being investigated in clinical practice. Several studies have reported that gargling with antioxidants, cryotherapy in which the development of free radicals in the oral cavity is prevented by reducing oral mucosal transfer of anticancer agents, and maintenance of a clean oral cavity achieved specific effects. [7][8][9][10] However, it is difficult to prevent and treat chemotherapyinduced mucositis, and symptomatic therapy is mainly performed in clinical practice. Thus, strategies against chemotherapy-induced mucositis should be established.Eriobotrya japonica seed extract (ESE), which was used in this study, was extracted from Eriobotrya japonica seeds with 70% EtOH. We previously confirmed that this extract contained various substances such as polyphenols, amino acids, and unsaturated fatty acids 11,12) ( Fig. 1). Furthermore, an in vitro study demonstrated the radical-scavenging actions of ESE. 11) In several in vivo studies, ESE was useful for treating rats with dimethylnitrosamine-induced hepatopathy, a rat nephropathy model prepared by administering adriamycin, an anticancer agent, and a rat inflammation model prepared by administering lipopolysaccharide comprising Gram-negative bacteria. We confirmed that these effects were achieved via the antioxidant actions of ESE.
12-14)These results suggest that ESE exhibits antioxidant and anti-inflammatory actions, and that this extract is useful for treating chemotherapy-induced mucositis. In this study, we investigated the effects of ESE using a hamster mucositis model prepared by 5-fluorouracil (5-FU) administration.
MATERIALS AND METHODS
MaterialsSufficiently sun-drided seeds of Mogi-loquant collected at Muroto and Susaki cities in Kochi Prefecture and Shimotsucho in Wakayama Prefecture of Japan were used. 5-Fluorouracil (5-FU) was provided by Kyowahakko (Japan). All other chemicals were of reagent grade.Preparation of ESE Eriobotrya...